Cas:89282-64-4 2-methoxybutan-1-amine manufacturer & supplier

We serve Chemical Name:2-methoxybutan-1-amine CAS:89282-64-4 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

2-methoxybutan-1-amine

Chemical Name:2-methoxybutan-1-amine
CAS.NO:89282-64-4
Synonyms:2-Methoxy-butylamin;1-Amino-2-methoxy-butan;2-Methoxy-n-butylamin;2-Methoxybutan-1-amine hydrochloride;1-Butanamine,2-methoxy;2-Methoxy-butylamine
Molecular Formula:C5H13NO
Molecular Weight:103.16300
HS Code:2922199090

Physical and Chemical Properties:
Melting point:N/A
Boiling point:126.9ºC at 760 mmHg
Density:0.849g/cm3
Index of Refraction:1.415
PSA:35.25000
Exact Mass:103.10000
LogP:1.07040

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like 2-Methoxy-butylamin chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,2-Methoxy-butylamine physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,2-Methoxybutan-1-amine hydrochloride Use and application,2-Methoxy-n-butylamin technical grade,usp/ep/jp grade.


Related News: Pharmaceutical intermediates and APIs belong to the fine chemical industry. 2-methoxybutan-1-amine manufacturer The Covington inquiry is significant because Lilly’s handling of any employee allegations is likely to be considered by U.S. prosecutors as they weigh whether there are grounds to pursue criminal charges, seek civil action, or decline to bring a case at all, several legal experts said. 2-methoxybutan-1-amine supplier Pharmaceutical intermediates and APIs belong to the fine chemical industry. 2-methoxybutan-1-amine vendor Especially tumor drugs with selective targeting characteristics. At present, about 80% of small drug (high-efficiency drug) APIs worldwide are patented drugs. 2-methoxybutan-1-amine factory The Covington inquiry is significant because Lilly’s handling of any employee allegations is likely to be considered by U.S. prosecutors as they weigh whether there are grounds to pursue criminal charges, seek civil action, or decline to bring a case at all, several legal experts said.